Paper Details

  1. Home
  2. Paper Details

AVP-825: a novel intranasal delivery system for low-dose sumatriptan powder in the treatment of acute migraine.

Author: SilbersteinStephen

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This study reviews the pharmacology, clinical efficacy, and tolerability of AVP-825, a new Breath Powered® nasal delivery system for low-dose sumatriptan. The review highlights the advantages of AVP-825 over traditional nasal sprays in terms of absorption time, efficacy, and suitability for use across multiple phases of a migraine attack.
Paper Details　
Original Abstract of the Article :
Migraine is a common, disabling disorder, and many patients remain dissatisfied with existing treatments. AVP-825 (ONZETRA® Xsail®) is a Breath Powered® exhalation delivery system for low-dose sumatriptan nasal powder (22 mg) that has been recently approved for use in the treatment of acute migraine...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/17512433.2017.1339600

データ提供：米国国立医学図書館（NLM）

AVP-825: A Breath of Fresh Air for Migraine Relief

Migraine, a debilitating neurological disorder, affects millions worldwide. This study explores AVP-825, a novel intranasal delivery system for sumatriptan, a medication commonly used to treat migraines. The researchers found that AVP-825, unlike traditional nasal sprays, offers faster absorption and early efficacy in treating acute migraines.

A New Era in Migraine Management

The study demonstrates a significant advancement in migraine treatment. The unique delivery system of AVP-825 provides a quicker and more effective means of delivering sumatriptan, potentially leading to faster relief and improved patient outcomes.

A Breath of Relief for Migraine Sufferers

This research offers hope for migraine sufferers seeking effective and convenient treatment options. The unique features of AVP-825 provide a promising alternative to traditional oral medications, offering faster relief and greater flexibility in managing migraine attacks.

Dr. Camel's Conclusion

AVP-825, like a refreshing breeze in the desert, brings a new wave of hope to migraine sufferers. Its unique delivery system offers faster absorption and earlier efficacy, providing a more convenient and effective treatment option for this debilitating condition.

Date :
  1. Date Completed 2017-08-04
  2. Date Revised 2017-08-04
Further Info :

Pubmed ID

28605258

DOI: Digital Object Identifier

10.1080/17512433.2017.1339600

Related Literature

Article Analysis
・Effects of sumatriptan nasal
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.